Loading
A phase 2 trial of F-MISO (JBS-003) run by Memorial Sloan Kettering Cancer Center, now recruiting.
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer is a phase 2 interventional study registered as NCT05491512 by Memorial Sloan Kettering Cancer Center, with 121 participants planned, started 2022-08-04. Conditions recorded: HPV, Throat Cancer, Oropharyngeal Carcinoma, Oropharyngeal Cancer and Human Papilloma Virus. Interventions recorded: 18 F-FMISO PET/CT, Radiation, Cisplatin, Carboplatin and 5-fluorouracil.
Shares F-MISO (JBS-003), Juniper Biosciences, Oropharyngeal cancer (tonsil and base of tongue) and the tag pipeline.
Shares F-MISO (JBS-003), Juniper Biosciences, Head and neck squamous cell carcinoma and the tag pipeline.
Shares Oropharyngeal cancer (tonsil and base of tongue), Head and neck squamous cell carcinoma and the tag pipeline.
Shares Oropharyngeal cancer (tonsil and base of tongue), Head and neck squamous cell carcinoma and the tag pipeline.
Shares Oropharyngeal cancer (tonsil and base of tongue), Head and neck squamous cell carcinoma and the tag pipeline.
Shares Oropharyngeal cancer (tonsil and base of tongue), Head and neck squamous cell carcinoma and the tag pipeline.
Shares Head and neck squamous cell carcinoma and the tag pipeline.
Shares Oropharyngeal cancer (tonsil and base of tongue) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/